chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: HEPA, YF
Symptoms: Laboratory test abnormal, Liver disorder, Pain
Clinical narrative: This case was reported by a consumer and described the occurrence of benign hepatic neoplasm in a 58 year old female subject who was vaccinated with hepatitis A vaccine inactivated Havrix, for prophylaxis. The reported is the subject. A physician or other health care professional has not verified this report. The subject's medical history included allergy to contrast dye, breast cancer, chemotherapy, radiation therapy, hypertension and hypothyroidism. Concurrent medications included thyroxine sodium Synthroid to treat hypothyroidism, Metoprolol succinate Toprol XL to treat hypertension, Anastrozole (Arimidex) to treat breast cancer, and nutritional supplementation with calcium sale and Linseed (Flax seed oil). On 4/22/2005 the subject received the 1st dose of Havrix (AHAVB043BA). On 4/22/2005, the subject was also vaccinated with yellow fever vaccine (YF Vax). On an unspecified date in July 2005, 2 months after vaccination with Havrix, the subject experienced rib pain. The subject was seen at a physicians office. The consumer reported that , a PET scan and ultrasound showed a 1.7cm mass in the liver, A biopsy showed that it was not cancerous. The events were ongoing at the time of initial reporting, 8/19/2005. On 8/31/2005, the consumer sent the pathology report from the liver biopsy. The biopsy was performed on 8/5/2005 and showed Hepatic parenchyma with focally dense lymphoid infiltrate, predominantly periportal, no evidence of metastatic mammary carcinoma, immunohistochemical staining for B and T cells (CD20 and CD3) showed a mixed infiltrate, most consistent with a reactive process. No further follow up information will be available.
Age: 14.0
Sex: F
Vaccine: HEPA
Symptoms: Injection site reaction, Medication error
Clinical narrative: This case was reported by a medical assistant and described the occurrence of an injection site reaction in a 13 year old female subject who was vaccinated with hepatitis A vaccine inactivated Havrix for prophylaxis. There were no concurrent medications. On an unspecified date before 9/13/2005, the subject received the 1st dose of Havrix. On 9/13/2005 the subject received the 2nd dose of Havrix in the right arm (lot AHAVB032AA). the medical assistant reported that the 2nd dose of Havrix was administered earlier then recommended. The recommended interval between the 1st and 2nd doses of Havrix is 6 to 12 months. on 9/13/2005, less than one day after vaccination of Havrix, the subject experienced an injection site reaction. At the time of initial reporting, 9/14/2005, the outcome of the injection site reaction was not reported. the healthcare professional considered the events to probably related to vaccination with Havrix.
Sex: U
Vaccine: HEPA
Symptoms: Hypersensitivity
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of allergy attack possibly due to latex (allergic reaction) in a subject of unspecified age and gender who was vaccinated with hepatitis A vaccine inactivated (Havrix) for prophylaxis. The healthcare professional reported that, some subjects experience an allergy attack possibly due to latex following the receipt of Havrix, however, subject identifiers were not provided. The healthcare professional reported that the subject, Had previously been established as being allergic to latex before the vaccine was administered. On an unspecified date on or before 9/26/2005, the subject received a dose of Havrix, in the 1440 EU, single dose prefilled syringe (dose number and lot number not provided). At an unspecified time after vaccination with Havrix, on an unspecified date on or before 9/26/2005, the subject experienced an allergic reaction to latex in the prefilled syringe. The outcome of the allergic reaction was not reported. The healthcare professional considered the allergic reaction to probably be related to vaccination with Havrix.
Age: 38.0
Sex: F
Vaccine: HEPA, TD
Symptoms: Dysgeusia
Clinical narrative: This case was reported by a nurse and described the occurrence of metallic taste in mouth a 37 year old female subject who was vaccinated with hepatitis A vaccine inactivated (Havrix) for prophylaxis. The subject has no known allergies. There were no concurrent medications. On 9/28/2005 the subject received 1st dose of Havrix (lot AHAVB078AB). On 09/28/2005, the subject was also vaccinated with tetanus and diphtheria toxoids absorbed (adult formulation). Approximately two weeks after the injections, on an unspecified date in 10/2005, the subject experienced metallic taste in mouth. The event was ongoing at the time of initial reporting, 11/2/2005.
Age: 31.0
Sex: M
Vaccine: FLU3, HEPA, TYP
Symptoms: Rash pruritic
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of a body rash in a 31 year old male subject who was vaccinated with hep A vaccine (Havrix) for prophylaxis. Influenza vaccine given on 22Dec05; influenza virus vaccine; given on 22Dec05; polysaccharide typhoid vaccine; unk given on 22Dec05. Concurrent medications included Decavac. On 22Dec05 the subject received a dose of Havrix (dose and lot number not specified). Concurrently on the same date, the subject also received injections of influenza virus vaccine (Fluzone); polysaccharide typhoid vaccine (Typhim Vi) and DeCavac. On 24Dec05, two days after vaccination with Havrix, the subject developed a pinpoint non pruritic body rash. At the time of reporting the event was unresolved. The healthcare professional considered the event was possibly related to vaccination with Havrix.
Age: 10.0
Sex: M
Vaccine: HEPA
Symptoms: Rash, Urticaria
Clinical narrative: This case was reported by a consumer and described the occurrence of a rash in a 10 yr old male subject who was vaccinated with hep A vaccine (Havrix) for prophylaxis. The reporter is the subject's mother. A physician or other healthcare professional has not verified this report. There were no concurrent medications. On 14Dec05 the subject received 2nd dose of Havrix (lot number not specified). On 16Dec05, two days after vaccination with Havrix, the subject experienced rash and urticaria. The subject was treated with diphenhydramine hydrochloride (Benadryl) and the evens resolved. The mother stated the rash and urticaria occurred again on 23Dec05, 24Dec05, and 25Dec05 and resolved each day after treatment with diphenhydramine hydrochloride (Benadryl).
Age: 18.0
Sex: M
Vaccine: FLU3, MNQ
Symptoms: Chills, Pyrexia, Tremor, Vaccine positive rechallenge
Clinical narrative: Case received from a healthcare professional on 20Oct05. A 18 year old male pt without relevant medical history had received his first IM injection of Menactra, batch number U1808AA and an IM dose of Fluzone, batch number U1753AA on 18Oct05 and within a few hours later, he developed high fever at 102, shaking and chills. The pt required doctor visit. He received acetaminophen (Tylenol). The fever decreased and the pt was better. However, he was not completely recovered at the time of the report. The pt had no known allergies but experienced high fever after his second dose of hep B vaccine. He did not present with any illness at time of vaccination and did not take medicines. Follow up information received from a health care provider on 28Nov05. There was no illness at the time of vaccination. At the time of this report, the pt had recovered. Further information is not expected.
Age: 15.0
Sex: M
Vaccine: MNQ
Symptoms: Asthenia, Back pain, Malaise, Tremor
Clinical narrative: A 15 year old male pt had received an IM injection of Menactra, lot number U1821AA, in the right arm on 25Oct05. 12 hrs after Menactra was administered the pt complained of general malaise, generalized shaking, weakness in the legs and back pain. The pt was seen in the physician's office the next day and received supportive care. Per the reporter, the pt recovered from these events on 28Oct05. Follow up information received on 19Dec05 from a health care provider. Per the reporter, Blecmycin given injection to wart on 25Oct05. Further information is not expected. A corrective version was created to amend co-manifestations to manifestations. Adverse events have been re ranked in this correction version (2).
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Confusional state, Disorientation, Ear pain
Clinical narrative: A 16 year old pt with no pre-existing medical history received an IM, left arm injection of Menactra, lot number U1821AA, on 13Dec05. That night, the parent reported that the pt became disoriented. He also seemed confused the next am and his ear was hurting. There was no illness at the time of vaccination. At the time of this report, the pt had recovered.
Age: 16.0
Sex: F
Vaccine: IPV
Symptoms: Asthenia, Rash pruritic
Clinical narrative: Pt. felt too weak to get out of bed the day after the IPV.  She developed a pruritic rash on her legs which was unresponsive to Benadryl.  There were no other vaccines administered and this was a booster shot only.
Age: 25.0
Sex: M
Vaccine: ANTH
Symptoms: Arthralgia, Back pain, Cellulitis, Gastrooesophageal reflux disease, Injection site hypersensitivity
Clinical narrative: Anthrax # 5 on 28 Feb 00, Noticed localized swelling that increased over the next several days. Treated for cellulitis. Swelling upper arm that extended to chest area. Resolved after 1-2 wks. Noticed new onset of Migraines 4 months post anthrax #4 with no worsening after anthrax # 5.  Current problems since anthrax # 5: Allergic rhinitis- symptom onset 8 months post Anthrax #5. Asthma- diagonsed > 2 yrs post AVA #5. Knee pain and GERD -onset > 2yrs post AVA #5 Back and neck pain-onset > 1yr post AVA #5
Age: 25.0
Sex: M
Vaccine: ANTH
Symptoms: Migraine, Neck pain, Rhinitis allergic, Swelling
Clinical narrative: Anthrax # 5 on 28 Feb 00, Noticed localized swelling that increased over the next several days. Treated for cellulitis. Swelling upper arm that extended to chest area. Resolved after 1-2 wks. Noticed new onset of Migraines 4 months post anthrax #4 with no worsening after anthrax # 5.  Current problems since anthrax # 5: Allergic rhinitis- symptom onset 8 months post Anthrax #5. Asthma- diagonsed > 2 yrs post AVA #5. Knee pain and GERD -onset > 2yrs post AVA #5 Back and neck pain-onset > 1yr post AVA #5
Age: 45.0
Sex: M
Vaccine: ANTH, UNK
Symptoms: Amblyopia, Arthralgia, Back pain, Blood cholesterol increased, Dizziness
Clinical narrative: Aches joints, acid reflux, amblyopia, high cholesterol, bumps on hand, balance(vertigo and dizziness), depression, headaches, ringing in ears, numbness and tingling arms, pain legs, pain groin, pain lower back, pain knees, rhinitis, insomnia, blood in stool, bursitis, cough, blisters in mouth, indigestion,
Age: 45.0
Sex: M
Vaccine: ANTH, UNK
Symptoms: Dyspepsia, Gastrooesophageal reflux disease, Groin pain, Haemorrhoids, Headache
Clinical narrative: Aches joints, acid reflux, amblyopia, high cholesterol, bumps on hand, balance(vertigo and dizziness), depression, headaches, ringing in ears, numbness and tingling arms, pain legs, pain groin, pain lower back, pain knees, rhinitis, insomnia, blood in stool, bursitis, cough, blisters in mouth, indigestion,
Age: 45.0
Sex: M
Vaccine: ANTH, UNK
Symptoms: Hypoaesthesia, Insomnia, Oral mucosal blistering, Rash, Tinnitus
Clinical narrative: Aches joints, acid reflux, amblyopia, high cholesterol, bumps on hand, balance(vertigo and dizziness), depression, headaches, ringing in ears, numbness and tingling arms, pain legs, pain groin, pain lower back, pain knees, rhinitis, insomnia, blood in stool, bursitis, cough, blisters in mouth, indigestion,
Age: 45.0
Sex: M
Vaccine: ANTH, UNK
Symptoms: Vertigo
Clinical narrative: Aches joints, acid reflux, amblyopia, high cholesterol, bumps on hand, balance(vertigo and dizziness), depression, headaches, ringing in ears, numbness and tingling arms, pain legs, pain groin, pain lower back, pain knees, rhinitis, insomnia, blood in stool, bursitis, cough, blisters in mouth, indigestion,
Age: 45.0
Sex: M
Vaccine: ANTH, UNK
Symptoms: Amblyopia, Arthralgia, Back pain, Blister, Blood cholesterol increased
Clinical narrative: Aches joints, acid reflux, amblyopia, high cholesterol, bumps on hand, balance(vertigo and dizziness), depression, headaches, ringing in ears, numbness and tingling arms, pain legs, pain groin, pain lower back, pain knees, rhinitis, insomnia, blood in stool, bursitis, cough, blisters in mouth, indigestion,
Age: 45.0
Sex: M
Vaccine: ANTH, UNK
Symptoms: Bursitis, Cough, Depression, Dizziness, Dyspepsia
Clinical narrative: Aches joints, acid reflux, amblyopia, high cholesterol, bumps on hand, balance(vertigo and dizziness), depression, headaches, ringing in ears, numbness and tingling arms, pain legs, pain groin, pain lower back, pain knees, rhinitis, insomnia, blood in stool, bursitis, cough, blisters in mouth, indigestion,
Age: 45.0
Sex: M
Vaccine: ANTH, UNK
Symptoms: Gastrooesophageal reflux disease, Groin pain, Haematochezia, Headache, Hypoaesthesia
Clinical narrative: Aches joints, acid reflux, amblyopia, high cholesterol, bumps on hand, balance(vertigo and dizziness), depression, headaches, ringing in ears, numbness and tingling arms, pain legs, pain groin, pain lower back, pain knees, rhinitis, insomnia, blood in stool, bursitis, cough, blisters in mouth, indigestion,
Age: 45.0
Sex: M
Vaccine: ANTH, UNK
Symptoms: Insomnia, Pain in extremity, Paraesthesia, Rash, Rhinitis
Clinical narrative: Aches joints, acid reflux, amblyopia, high cholesterol, bumps on hand, balance(vertigo and dizziness), depression, headaches, ringing in ears, numbness and tingling arms, pain legs, pain groin, pain lower back, pain knees, rhinitis, insomnia, blood in stool, bursitis, cough, blisters in mouth, indigestion,
Age: 45.0
Sex: M
Vaccine: ANTH, UNK
Symptoms: Tinnitus, Vertigo
Clinical narrative: Aches joints, acid reflux, amblyopia, high cholesterol, bumps on hand, balance(vertigo and dizziness), depression, headaches, ringing in ears, numbness and tingling arms, pain legs, pain groin, pain lower back, pain knees, rhinitis, insomnia, blood in stool, bursitis, cough, blisters in mouth, indigestion,
Sex: M
Vaccine: PPV, PPV
Symptoms: Oedema, Pain, Swelling
Clinical narrative: Information has been received from a pharmacist concerning an elderly male who was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (lot #651320/1008P). Concomitant therapy included an unspecified thyroid medication and naproxen. Subsequently the patient developed cellulitis, burning and redness at the injection site. The patient sought medical attention and was treated with cephalexin (KEFLEX). Subsequently, the patient recovered. the reporting pharmacist considered cellulitis, burning and redness at the injection to be other important medical events (OMIC). Additional information has been requested. No product quality complaint was involved.
Sex: M
Vaccine: PPV, PPV
Symptoms: Cellulitis, Injection site hypersensitivity, Injection site reaction, Skin burning sensation
Clinical narrative: Information has been received from a pharmacist concerning an elderly male who was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (lot #651320/1008P). Concomitant therapy included an unspecified thyroid medication and naproxen. Subsequently the patient developed cellulitis, burning and redness at the injection site. The patient sought medical attention and was treated with cephalexin (KEFLEX). Subsequently, the patient recovered. the reporting pharmacist considered cellulitis, burning and redness at the injection to be other important medical events (OMIC). Additional information has been requested. No product quality complaint was involved.
Age: 0.32
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Abnormal faeces, Aphasia, Autism, Communication disorder, Decreased eye contact
Clinical narrative: Fever, Baby who always babbled went silent for 3 days then watched as his communication faded to almost nothing in 2 weeks. Showed and diagnosed with soft signs of autism, due to therimisol in shots. Eye contact problems etc. Also baby's stools changed exactly day of 2 and 4 months shots. Irritability etc. She Still does not babble as well as he did at age 3.5 months. Eye contact issues as well. 04/01/2010 He is considered speech delayed for his age and eye contact problems. I am positive this was due to loss of babbing skills from 4 month vaccines.
Age: 0.32
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Irritability, Pyrexia, Staring
Clinical narrative: Fever, Baby who always babbled went silent for 3 days then watched as his communication faded to almost nothing in 2 weeks. Showed and diagnosed with soft signs of autism, due to therimisol in shots. Eye contact problems etc. Also baby's stools changed exactly day of 2 and 4 months shots. Irritability etc. She Still does not babble as well as he did at age 3.5 months. Eye contact issues as well. 04/01/2010 He is considered speech delayed for his age and eye contact problems. I am positive this was due to loss of babbing skills from 4 month vaccines.
Age: 60.0
Sex: M
Vaccine: TYP
Symptoms: Erythema, Rash pruritic
Clinical narrative: Started taking oral typhoid tabs on 02/05/2006 - had onset of rash on 02/07/2006 - began at antecubital space, moved down inner arms, then back of neck, chest, trunk and inlet ankles/calves.  Rash was fine, red, and itchy.  Duration approximately 3 weeks - almost fully resolved at this time.  No treatment.
Age: 36.0
Sex: F
Vaccine: HEP, HEPA, JEV
Symptoms: Back pain, Headache, Hypoaesthesia, Nausea, Vomiting
Clinical narrative: 10:00PM - States had headache, nausea, vomiting, left arm numbness, mid-back pain.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Cough, Drug ineffective, Nasal congestion, Viral infection
Clinical narrative: Information has been received from a health professional concerning a 7 year old female who on 7/19/1999 was vaccinated with a dose of varicella virus vaccine live. Within the past month, in 2/2006, the patient developed breakthrough chickenpox characterized by less than 50 lesions, cough and congestion. She was treated with acetaminophen (Tylenol) and a cough suppressant. Unspecified medical attention was sought. The patients outcome was not reported. there was no product quality complaint involved. Chickenpox characterized by less than 50 lesions, cough and congestion were considered to be other important medical events (OMIC). Additional information has been requested.
Age: 56.0
Sex: F
Vaccine: PPV
Symptoms: Anorexia, Breast disorder female, Diarrhoea, Drug ineffective, Hyperplasia
Clinical narrative: Common variable immunodeficiency presenting as lymphonodular hyperplasia pernicious anemia and breast cancer. Journal of Allergy and Clinical Immunology 2006:S110-S110. Information has been received from a published literature abstract concerning a 56 year old female with a history of treated right breast cancer 7 years prior, now in remission, presented with weight loss, anorexia, and loose stools. She was previously well, without fevers. She was a nonsmoker, had no history of recurrent infections and had no significant family or environmental history. Initial workup revealed a macrocytosis and she was found to have pernicious anemia. Chest x-ray was negative. EGD showed diffuse, circumferential, nodular thickening of the entire duodenum. Biopsies showed non-specific inflammation. Colonoscopy was normal. Small bowel series and abdominal CT with contrast showed similar appearance of entire small bowel without lymphadenopathy. Jejunal biopsies showed lymphonodular hyperplasia. IgA was <15 mg/dL, IgM was 19 mg/dL, and IgG was 687 mg/dL. She was protected to tetanus but had no protection to pneumococcus, despite vaccination attempts with both conjugated and unconjugated vaccines (manufacturers unknown). Sinus CT showed mild pan-sinusitis. Chest CT showed right upper lobe ground glass infiltrate. Lung biopsy revealed metastatic breast cancer. The patient was diagnosed with pernicious anemia, lymphonodular hyperplasia, CVID, and metastatic breast cancer, CVID has been associated with all of these conditions. The patient never experienced the infections so commonly seen with CVID. The workup leading to the final diagnosis stemmed primarily from the discovery of lymphonodular hyperplasia. Upon internal review, the patient's breast cancer metastatic was considered an other medical event (OMIC). No further information is available. A copy of the published literature abstract has been attach as further documentation of the patient's experience.
Age: 56.0
Sex: F
Vaccine: PPV
Symptoms: Immune system disorder, Immunoglobulins decreased, Inflammation, Laboratory test abnormal, Macrocytosis
Clinical narrative: Common variable immunodeficiency presenting as lymphonodular hyperplasia pernicious anemia and breast cancer. Journal of Allergy and Clinical Immunology 2006:S110-S110. Information has been received from a published literature abstract concerning a 56 year old female with a history of treated right breast cancer 7 years prior, now in remission, presented with weight loss, anorexia, and loose stools. She was previously well, without fevers. She was a nonsmoker, had no history of recurrent infections and had no significant family or environmental history. Initial workup revealed a macrocytosis and she was found to have pernicious anemia. Chest x-ray was negative. EGD showed diffuse, circumferential, nodular thickening of the entire duodenum. Biopsies showed non-specific inflammation. Colonoscopy was normal. Small bowel series and abdominal CT with contrast showed similar appearance of entire small bowel without lymphadenopathy. Jejunal biopsies showed lymphonodular hyperplasia. IgA was <15 mg/dL, IgM was 19 mg/dL, and IgG was 687 mg/dL. She was protected to tetanus but had no protection to pneumococcus, despite vaccination attempts with both conjugated and unconjugated vaccines (manufacturers unknown). Sinus CT showed mild pan-sinusitis. Chest CT showed right upper lobe ground glass infiltrate. Lung biopsy revealed metastatic breast cancer. The patient was diagnosed with pernicious anemia, lymphonodular hyperplasia, CVID, and metastatic breast cancer, CVID has been associated with all of these conditions. The patient never experienced the infections so commonly seen with CVID. The workup leading to the final diagnosis stemmed primarily from the discovery of lymphonodular hyperplasia. Upon internal review, the patient's breast cancer metastatic was considered an other medical event (OMIC). No further information is available. A copy of the published literature abstract has been attach as further documentation of the patient's experience.
Age: 56.0
Sex: F
Vaccine: PPV
Symptoms: Neoplasm malignant, Pernicious anaemia, Sinusitis, Weight decreased
Clinical narrative: Common variable immunodeficiency presenting as lymphonodular hyperplasia pernicious anemia and breast cancer. Journal of Allergy and Clinical Immunology 2006:S110-S110. Information has been received from a published literature abstract concerning a 56 year old female with a history of treated right breast cancer 7 years prior, now in remission, presented with weight loss, anorexia, and loose stools. She was previously well, without fevers. She was a nonsmoker, had no history of recurrent infections and had no significant family or environmental history. Initial workup revealed a macrocytosis and she was found to have pernicious anemia. Chest x-ray was negative. EGD showed diffuse, circumferential, nodular thickening of the entire duodenum. Biopsies showed non-specific inflammation. Colonoscopy was normal. Small bowel series and abdominal CT with contrast showed similar appearance of entire small bowel without lymphadenopathy. Jejunal biopsies showed lymphonodular hyperplasia. IgA was <15 mg/dL, IgM was 19 mg/dL, and IgG was 687 mg/dL. She was protected to tetanus but had no protection to pneumococcus, despite vaccination attempts with both conjugated and unconjugated vaccines (manufacturers unknown). Sinus CT showed mild pan-sinusitis. Chest CT showed right upper lobe ground glass infiltrate. Lung biopsy revealed metastatic breast cancer. The patient was diagnosed with pernicious anemia, lymphonodular hyperplasia, CVID, and metastatic breast cancer, CVID has been associated with all of these conditions. The patient never experienced the infections so commonly seen with CVID. The workup leading to the final diagnosis stemmed primarily from the discovery of lymphonodular hyperplasia. Upon internal review, the patient's breast cancer metastatic was considered an other medical event (OMIC). No further information is available. A copy of the published literature abstract has been attach as further documentation of the patient's experience.
Age: 55.0
Sex: M
Vaccine: HEPA, TD, TYP
Symptoms: Granuloma, Headache, Laboratory test abnormal, Myelitis, Skin ulcer
Clinical narrative: Seriousness Criteria: Other - Medically Significant (OMIC). Initial report received from a literature citation on 27/Feb/2006. A 55 year old male patient with no reported medical history had received tetanus/diphtheria toxoid, hepatitis A and typhoid vaccinations on an unspecified date in preparation for a trip. The trade names, manufacturers and lot numbers were not reported for any of the products. Seven days post-vaccination the patient noted episodes of shooting pain in the right occipital region, superior and posterior to the right ear and rarely in the right anterior neck. Each attack of pain lasted one to two seconds. Initially the pain was mild, but over the next three day, it increased in severity and frequency. The maximum frequency was ten to 20 attacks per hours. The pain was eventually rated eight of ten in severity. There were no cranial autonomic features. Touching or turning the head did not trigger the pain, and there was no Lhermitte sign. After seven days, the shooting pain resolved. Following this, the patient had mild tenderness in the right occipital region for a few days. He had been pain-free for eight days at the time of neurologic consultation. His neurologic examination was normal aside from decreased pain and temperature sensation in a small area posterior to the right ear. Occipital nerve tenderness was absent, and there were no occipital skin lesions. MRI of the brain with gadolinium was normal. MRI of the cervical spine nine days after the shooting pain ended revealed a small area of increased T2 signal in the central spinal cord at the C2 level. The lesion showed contrast enhancement. The following tests were normal; sedimentation rate, B12, vitamin E, Folate angiotensin converting enzyme, myeloperoxidase, proteinase, antinuclear antibody, anti-DS-DNA, antibody to extractable nuclear antigen, comprehensive paraneoplastic panel, Lyme screen, and syphilis serology. Spinal fluid examination was normal aside from a mildly elevated protein of 54 mg/dL. The CSF IgG index was normal, and the synthesis rate was zero. There was one oligoclonal band (within normal limits), and CSF cytology was normal. A chest radiography revealed a calcified granuloma at the left apex. The patient remained pain-free in the following months. Follow-up MRI ten weeks later showed resolution of the abnormal signal and enhancement within the cervical spinal cord. The patient had spontaneous remission of pain. The impression was that the patient demonstrated a clinically isolated syndrome of C2 myelitis.
Age: 55.0
Sex: M
Vaccine: HEPA, TD, TYP
Symptoms: Tenderness
Clinical narrative: Seriousness Criteria: Other - Medically Significant (OMIC). Initial report received from a literature citation on 27/Feb/2006. A 55 year old male patient with no reported medical history had received tetanus/diphtheria toxoid, hepatitis A and typhoid vaccinations on an unspecified date in preparation for a trip. The trade names, manufacturers and lot numbers were not reported for any of the products. Seven days post-vaccination the patient noted episodes of shooting pain in the right occipital region, superior and posterior to the right ear and rarely in the right anterior neck. Each attack of pain lasted one to two seconds. Initially the pain was mild, but over the next three day, it increased in severity and frequency. The maximum frequency was ten to 20 attacks per hours. The pain was eventually rated eight of ten in severity. There were no cranial autonomic features. Touching or turning the head did not trigger the pain, and there was no Lhermitte sign. After seven days, the shooting pain resolved. Following this, the patient had mild tenderness in the right occipital region for a few days. He had been pain-free for eight days at the time of neurologic consultation. His neurologic examination was normal aside from decreased pain and temperature sensation in a small area posterior to the right ear. Occipital nerve tenderness was absent, and there were no occipital skin lesions. MRI of the brain with gadolinium was normal. MRI of the cervical spine nine days after the shooting pain ended revealed a small area of increased T2 signal in the central spinal cord at the C2 level. The lesion showed contrast enhancement. The following tests were normal; sedimentation rate, B12, vitamin E, Folate angiotensin converting enzyme, myeloperoxidase, proteinase, antinuclear antibody, anti-DS-DNA, antibody to extractable nuclear antigen, comprehensive paraneoplastic panel, Lyme screen, and syphilis serology. Spinal fluid examination was normal aside from a mildly elevated protein of 54 mg/dL. The CSF IgG index was normal, and the synthesis rate was zero. There was one oligoclonal band (within normal limits), and CSF cytology was normal. A chest radiography revealed a calcified granuloma at the left apex. The patient remained pain-free in the following months. Follow-up MRI ten weeks later showed resolution of the abnormal signal and enhancement within the cervical spinal cord. The patient had spontaneous remission of pain. The impression was that the patient demonstrated a clinically isolated syndrome of C2 myelitis.
Age: 0.18
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Apnoea, Crying
Clinical narrative: High pitch cry for 2 hours, 3 Apneic episodes.
Age: 43.0
Sex: M
Vaccine: SMALL
Symptoms: Cardiomyopathy, Chest pain, Dyspnoea, Electrocardiogram abnormal, Heart rate increased
Clinical narrative: Shot received 01/25/2004, approx 2 weeks later started with shortness of breath and elevated heart rate on mild exertion. On evening of 02/27 started mild chest pain, increasing thru next day when hospitalized. Information received from Discharge summary states Myocarditis, cardiomyopathy, hypertension as symptoms. msv Medical records state fever. msv
Age: 43.0
Sex: M
Vaccine: SMALL
Symptoms: Hypertension, Laboratory test abnormal, Myocarditis, Pyrexia
Clinical narrative: Shot received 01/25/2004, approx 2 weeks later started with shortness of breath and elevated heart rate on mild exertion. On evening of 02/27 started mild chest pain, increasing thru next day when hospitalized. Information received from Discharge summary states Myocarditis, cardiomyopathy, hypertension as symptoms. msv Medical records state fever. msv
Age: 51.0
Sex: M
Vaccine: ANTH
Symptoms: Arthralgia, Fluid retention, Headache, Joint stiffness, Pain
Clinical narrative: Headache, joint stiffness, joint ache, skin pain, skin turns a funny color at times, skin papules filled with clear fluid, when papules broke fluid burned skin and was extremely painful, vision, poor tolerance for bright lights.
Age: 51.0
Sex: M
Vaccine: ANTH
Symptoms: Photophobia, Rash papular, Skin discolouration, Visual disturbance
Clinical narrative: Headache, joint stiffness, joint ache, skin pain, skin turns a funny color at times, skin papules filled with clear fluid, when papules broke fluid burned skin and was extremely painful, vision, poor tolerance for bright lights.
Age: 0.81
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia, Rash, Roseola
Clinical narrative: Started fever on 02/28/2006 Mom called and reported still had fever on 3/3/06. Tylenol controlled fever. No local rxn. 3/4/06 developed a rash, fever gone, poss roseola.
Age: 59.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site pain, Nausea, Vomiting
Clinical narrative: Pt reports redness, swelling, pain at site. Also reports nausea and vomiting since she received medication (vaccine). Pt has been using Tylenol for pain.
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Herpes zoster, Rash
Clinical narrative: Pt had Varivax 8/9/04. No history of chickenpox. 3/1 Began with rash on face in Trigeminal nerve pattern, shingles forehead, side nose and eye.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site nodule, Injection site oedema, Injection site pain
Clinical narrative: Pt developed soreness of arm. Pneumovax given in (extending from shoulder to elbow and toward breast). She also had multiple red swollen nodules. No fever.
Age: 43.0
Sex: F
Vaccine: MNQ
Symptoms: Asthenia, Injection site erythema, Injection site pain
Clinical narrative: 1 min after vaccination injected pt began complaining of severe pain in her left arm from injection site down to her hand. Pain peaked after 7-8 minutes and then stabilized. Feeling weakness in hand. Given ice pack, Motrin 400mg and Tylenol 500mg. Vitals stable. Exam nl, mild erythema at site which resolved after 15 min. Pt reported continued weakness in hand. But her exam was otherwise nl.
Age: 35.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Feeling hot, Injection site induration, Tenderness
Clinical narrative: 5cm x 7.5cm area of erythema, induration, heat and tenderness.
Age: 53.0
Sex: F
Vaccine: TD
Symptoms: Blister, Feeling hot, Hypoaesthesia, Injection site erythema, Injection site induration
Clinical narrative: Facial numbness, pruritis, aching lower limbs, malaise, edema, induration redness and warmth at site, fever blisters on lips.
Age: 53.0
Sex: F
Vaccine: TD
Symptoms: Malaise, Myalgia, Oedema, Pruritus
Clinical narrative: Facial numbness, pruritis, aching lower limbs, malaise, edema, induration redness and warmth at site, fever blisters on lips.
Age: 28.0
Sex: F
Vaccine: TD
Symptoms: Injection site pain
Clinical narrative: Spoke to pt on phone states she is having severe pain at vaccination site x3d. Denies redness or swelling. As pt is now on travel, advised her to be seen locally. Pt agreeable.
Age: 6.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Feeling hot, Injection site erythema, Injection site oedema
Clinical narrative: Local redness and edema right arm from shoulder to elbow area warm to touch. Ice to area for 20 min at a time. Ibuprofen prn.
Age: 53.0
Sex: F
Vaccine: HEPAB, TTOX, TYP
Symptoms: Decreased appetite, Dizziness, Headache, Nausea, Pyrexia
Clinical narrative: Received phone call from client. C/o dizziness, HA, nausea (loss of appetite), and fever with onset 3/8/06. Reports has lost 5 lbs in 4 days. C/o cold symptoms prior to receiving vaccines on 3/6/06.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Feeling hot, Injection site erythema, Injection site oedema
Clinical narrative: Left arm area of MMR injection, red, swollen, warm to touch. Atarax syrup ordered per CNP.
Age: 1.0
Sex: M
Vaccine: PNC, VARCEL
Symptoms: Injection site vesicles
Clinical narrative: Cluster of vesicles at site of VZV administration left thigh. 4 other scabs on trunk and leg.
Age: 40.0
Sex: F
Vaccine: TYP, YF
Symptoms: Asthenia, Dizziness, Erythema, Hypoaesthesia
Clinical narrative: Pt experienced moderate reaction to the yellow fever vaccination. Pt c/o dizziness, weakness, numbness around neck, and reddening of facial skin. Pt was immediately referred to physician for observation. Pt was monitored in the clinic for 30 minutes and prescribed benedryl, 20mg of prednisone, and given an epipen. Shortly thereafter pt was released due to normal vitals/blood pressure 108/60.
Age: 0.96
Sex: F
Vaccine: IPV, MMR, VARCEL
Symptoms: Erythema multiforme, Stevens-Johnson syndrome
Clinical narrative: Erythema multiforme major (OMIC). 3/17/06 Per f/u with vaccine provider, IPV was also given on 3/10/06. Other additions-corrections made as indicated. 3/21/06 Added Stevens Johnson Syndrome per FDA researcher request. Review of medical record confirms diagnosis of erythema multiforme triggered by recent vaccines or Amoxicillin.  Follow-up: See note (scanned medical records).
Age: 1.02
Sex: F
Vaccine: FLU3, MMR, VARCEL
Symptoms: Blister, Rash papular, Viral infection
Clinical narrative: Papules, vesicles, scabbed vesicles 50 on legs trunk and face. Dx: chicken pox post vaccination. Tx: Acyclovir.
Age: 15.0
Sex: F
Vaccine: HEPA
Symptoms: Feeling hot, Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: Redness/pain and swelling, warm to touch on left deltoid region.
Age: 6.0
Sex: M
Vaccine: DTAP, MMR, VARCEL
Symptoms: Convulsion, Feeling hot, Injection site erythema, Injection site oedema
Clinical narrative: Injection site red and swollen (moderate) and warm to touch (left leg). Seizure at 24 hrs after vaccine. Eval at ER.
Age: 46.0
Sex: M
Vaccine: TD
Symptoms: Feeling hot, Hyperhidrosis, Injection site erythema, Pyrexia
Clinical narrative: Fever, sweats noticed 3/8/06, redness and warmth feeling to injection site on 3/9/06.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia, Rash vesicular, Viral infection
Clinical narrative: Low grade fever, widespread vesicles. Dx: varicella post vaccination. Tx: Zovirax, Bactroban 2%.
Age: 1.01
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash vesicular, Viral infection
Clinical narrative: Wide spread vesicles. Dx: Varicella post vaccine. Tx: Acyclovir.
Age: 1.03
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Pyrexia, Rash papular, Rash vesicular, Viral infection
Clinical narrative: Temp 102, scattered papules in different stages. Dx: Chickenpox post vaccination. Tx: Zovirax 800 mg 1 PO qid x 5 days.
Age: 1.01
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular, Skin ulcer, Viral infection
Clinical narrative: Scattered lesions (25-50), Dx: chicken pox post vaccination, Tx: Acyclovir 200/s, 2tsp PO qid x 5 days.
Age: 1.02
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash macular, Rash papular, Viral infection
Clinical narrative: Papules/Macules scattered, Dx: chicken pox post vaccination, Tx: Atarax, Bactroban.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Erythema, Rash vesicular, Viral infection
Clinical narrative: Vesicles, erythema, widespread. Dx: chicken pox post vaccination. Tx: Acyclovir, Bactroban cream.
Age: 1.08
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash vesicular, Skin ulcer, Viral infection
Clinical narrative: Lesions of varying stages widespread. Dx: Chicken pox post vaccination. Tx: symptomatic.
Age: 1.63
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Drug ineffective, Viral infection
Clinical narrative: Widespread vesicles, DX chickenpox post vaccination, TX  Atarax. Vaccine given 2/11/1998, Adverse event onset 2/20/2006.
Age: 1.01
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Blister, Drug ineffective, Rash papular, Viral infection
Clinical narrative: Vesicles, papules and scabbed vesicles scattered <20, DX chicken pox post vaccination, TX Acyclovir. Vaccine given 4/18/2000, DX on 2/20/2006.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Drug ineffective, Erythema, Viral infection
Clinical narrative: Widespread erythema, vesicles <50 DX chicken pox post vaccination, TX Acyclovir, Vaccine given 4/17/1997, DX 2/27/2006.
Age: 1.52
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Drug ineffective, Viral infection
Clinical narrative: Numerous pox vesicles, widespread DX chickenpox 03/01/2006, post vaccination 05/05/1998, TX Acyclovir.
Age: 1.01
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Blister, Drug ineffective, Viral infection
Clinical narrative: Widespread vesicles, DX chickenpox 03/02/2006, post vaccination 11/29/1999, TX Acyclovir.
Age: 1.06
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Petechiae, Rash macular, Rash papular
Clinical narrative: Papules, macules scattered papules to face back, no vesicles but small head to center Petechiae to left neck.
Age: 1.05
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Blister, Viral infection
Clinical narrative: Widespread vesicles, DX chickenpox , post vaccination , TX Acyclovir.
Age: 1.02
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Blister, Drug ineffective, Erythema, Rash macular, Rash papular
Clinical narrative: Papules, macules, erythema, vesicles widespread, DX chickenpox 03/03/2006, post vaccination 09/19/1997 TX Acyclovir.
Age: 1.02
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Viral infection
Clinical narrative: Papules, macules, erythema, vesicles widespread, DX chickenpox 03/03/2006, post vaccination 09/19/1997 TX Acyclovir.
Age: 1.26
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Drug ineffective, Viral infection
Clinical narrative: Wide spread vesicles DX chickenpox 03/03/2006, post vaccination 10/08/2001, TX Acyclovir.
Age: 1.95
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Skin ulcer, Viral infection
Clinical narrative: 10-15 chicken pox lesions. DX Chicken pox 03/07/2006, post varicella vaccine 10/24/2000, TX Acyclovir.
Age: 1.03
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Blister, Drug ineffective, Viral infection
Clinical narrative: Widespread vesicles all different stages <25 DX chickenpox 03/08/2006, post vaccination 12/11/2000, TX symptomatic.
Age: 1.02
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Blister, Pyrexia, Rash papular, Skin ulcer, Viral infection
Clinical narrative: Temp 102, raised papular lesions all over with blistering, DX chickenpox, post vaccination, TX Acyclovir.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Atherosclerosis, Coronary artery disease, Injection site erythema, Injection site swelling, Pulmonary oedema
Clinical narrative: VACCINE ADMINISTERED 10/31/2005. PT RETURNED TO CLINIC 11/1/2005 COMPLAINING OF REDNESS AND SWELLING IN ARM WHERE VACCINE WAS ADMINISTERED. SOLUMEDROL 125 MG GIVEN IM. ON 11/8/2005 PT RETURNED TO CLINIC FOR FOLLOW-UP AT WHICH TIME SHE FELT BETTER. PT STATED FEELING "CREEPY, CRAWLY" HAD DIMINISHED. PT WAS TAKING BENADRYL AND AYRTEC AT THAT TIME, BUT HAD STOPPED TAKING PREDNISONE DUE TO HYPERACTIVITY. 3/28/06 Received autopsy report which revealed COD as coronary artery atherosclerosis (years)/ss
Age: 27.0
Sex: F
Vaccine: HEP, HEPA, TD
Symptoms: Blood pressure decreased, Loss of consciousness
Clinical narrative: Patient passed out after receiving vaccines. Elevated legs and put patient in supine position.  B/P taken 90/60, pulse 92, alert.  Patient was monitored for the next 45 minutes.  B/P stable at 110/70; pulse 88.  Discharged with brother at 11:45am.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Cyst, Feeling hot, Hypoaesthesia, Neuralgia, Pain
Clinical narrative: 11-5-05:  Flu vaccine at flu clinic and worked in yard. 11-7-05:  Complained of aches, pains, tingling, numbness and heat all over  - down spine and down to right major toe, right thumb, left shoulder, but mainly in her neck and spine. 11-17-05: Saw family doctor and was referred for MRI of neck and had blood test.  Put on anti-inflammatory meds and Aciphex 11-23-05: Referred for MRi of thoracic region. 12-01-05: Family doctor referred patient to neurologist for evaluation of arachnoid cyst and disc problem in neck. 12-05-05: Saw neurologist who told her about cyst on spine and that the flu shot or any shot can cause neuralgia. Referred her to a neurosurgeon and placed on muscle relaxant. 12-13-05: Saw neurosurgeon.  He told her the cyst may have been there since birth or from an accident and they would just monitor it.  The neuralagia was from inflammation and he felt that it was from the flu vaccine.  Patient is concerned and does this mean that she should not get anymore flu shots in the future? and she wants to know if anyone else has ever had this happen to them?
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia
Clinical narrative: 11-5-05:  Flu vaccine at flu clinic and worked in yard. 11-7-05:  Complained of aches, pains, tingling, numbness and heat all over  - down spine and down to right major toe, right thumb, left shoulder, but mainly in her neck and spine. 11-17-05: Saw family doctor and was referred for MRI of neck and had blood test.  Put on anti-inflammatory meds and Aciphex 11-23-05: Referred for MRi of thoracic region. 12-01-05: Family doctor referred patient to neurologist for evaluation of arachnoid cyst and disc problem in neck. 12-05-05: Saw neurologist who told her about cyst on spine and that the flu shot or any shot can cause neuralgia. Referred her to a neurosurgeon and placed on muscle relaxant. 12-13-05: Saw neurosurgeon.  He told her the cyst may have been there since birth or from an accident and they would just monitor it.  The neuralagia was from inflammation and he felt that it was from the flu vaccine.  Patient is concerned and does this mean that she should not get anymore flu shots in the future? and she wants to know if anyone else has ever had this happen to them?
Age: 27.0
Sex: M
Vaccine: SMALL
Symptoms: Chest discomfort, Fatigue, Myalgia
Clinical narrative: Fatigue and myalgias started approximately 2 weeks after the Vaccinia given.  Chest discomfort began approximately 2 weeks after the vaccine.
Age: 1.25
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash, Swelling
Clinical narrative: 10 days after receiving MMR vaccine:  Low grade fever followed by severe rash covering legs (plus swelling), arms, belly back, face (plus swelling).  Rash did not clear completely for another 10 days. No treatment given.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Oedema peripheral, Tenderness
Clinical narrative: Taken to ER 2-22-06 more than 24 hours after immunizations given.R. arm tender swollen, warm and red from elbow to shoulder, temp. 97.3, Motrin given and told to continue at home. Brought to Health Dept. 8am 2-23-06 as no improvement. Arm was still swollen warm and red but child not in any distress and no fever. Parent was reassured and told to continue Motrin.
Age: 26.0
Sex: M
Vaccine: FLUX, SMALL, FLUX, SMALL
Symptoms: Fatigue, Injection site pain, Laboratory test abnormal, Myocarditis, Pulmonary oedema
Clinical narrative: RECEIVED BOTH SMALLPOX AND INACTIVATED INFLUENZA VACCINES ON 11/18/2005.  HE PRESENTED TO THE VACCINE HEALTHCARE CENTER ON 12/01/05 FOR EVALUATION OF FATIGUE, FEVERS, POOR SLEEP, LEFT SHOULDER PERSISTENT PAIN, AND CONCERNS REGARDING HIS INOCULATION SITE.  THE PATIENT WAS EXAMINED AND FOUND TO HAVE AN ORAL TEMPERATURE OF 99.2F.  HE DID APPEAR FATIGUED.  HE WAS DIAGNOSED AS HAVING A ROBUST REACTION AND SENT HOME ON CLARITIN, MOTRIN, AND LIDEX CREME. THE PATIENT CONTINUED WITH FATIGUE ON THE FOLLOWING TWO DAYS BUT NEVER COMPLAINED OF CHEST PAIN OR SHORTNESS OF BREATH. THE PATIENT WAS FOUND DECEASED IN HIS BARRACKS BED ON THE MORNING OF 12/04/05. ACLS PROTOCOL WAS INITIATED IN THE FIELD AND CONTINUED IN THE HOSPITAL EMERGENCY ROOM TO NO AVAIL.   THE PATIENT WAS PRONOUNCED DEAD AT 0933 HOURS. THE PATIENT'S INITIAL AUTOPSY WAS NEGATIVE FOR ANY SIGNS OF FOUL PLAY, FRACTURE, ACUTE INJURY, TRAUMA, ALCOHOL OR ILLICIT DRUG INTOXICATION OR OVERDOSE. 8/3/06 Received medical records & autopsy report which stated COD as hypersensitivity myocarditis.  Final autopsy diagnoses also include sudden death in apparent healthy 26 year old; history of recent smallpox & flu vax; lymphocytic eosinophilic myocarditis, pulmonary edema.
Age: 26.0
Sex: M
Vaccine: FLUX, SMALL, FLUX, SMALL
Symptoms: Pyrexia, Shoulder pain, Sleep disorder, Sudden death
Clinical narrative: RECEIVED BOTH SMALLPOX AND INACTIVATED INFLUENZA VACCINES ON 11/18/2005.  HE PRESENTED TO THE VACCINE HEALTHCARE CENTER ON 12/01/05 FOR EVALUATION OF FATIGUE, FEVERS, POOR SLEEP, LEFT SHOULDER PERSISTENT PAIN, AND CONCERNS REGARDING HIS INOCULATION SITE.  THE PATIENT WAS EXAMINED AND FOUND TO HAVE AN ORAL TEMPERATURE OF 99.2F.  HE DID APPEAR FATIGUED.  HE WAS DIAGNOSED AS HAVING A ROBUST REACTION AND SENT HOME ON CLARITIN, MOTRIN, AND LIDEX CREME. THE PATIENT CONTINUED WITH FATIGUE ON THE FOLLOWING TWO DAYS BUT NEVER COMPLAINED OF CHEST PAIN OR SHORTNESS OF BREATH. THE PATIENT WAS FOUND DECEASED IN HIS BARRACKS BED ON THE MORNING OF 12/04/05. ACLS PROTOCOL WAS INITIATED IN THE FIELD AND CONTINUED IN THE HOSPITAL EMERGENCY ROOM TO NO AVAIL.   THE PATIENT WAS PRONOUNCED DEAD AT 0933 HOURS. THE PATIENT'S INITIAL AUTOPSY WAS NEGATIVE FOR ANY SIGNS OF FOUL PLAY, FRACTURE, ACUTE INJURY, TRAUMA, ALCOHOL OR ILLICIT DRUG INTOXICATION OR OVERDOSE. 8/3/06 Received medical records & autopsy report which stated COD as hypersensitivity myocarditis.  Final autopsy diagnoses also include sudden death in apparent healthy 26 year old; history of recent smallpox & flu vax; lymphocytic eosinophilic myocarditis, pulmonary edema.